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SUMMARY
More than 36000 individuals living in rural Malawi were skin tested with antigens derived
from 12 different species of environmental mycobacteria. Most were simultaneously tested with
RT23 tuberculin, and all were followed up for both tuberculosis and leprosy incidence. Skin
test results indicated widespread sensitivity to the environmental antigens, in particular to
Mycobacterium scrofulaceum, M. intracellulare and one strain of M. fortuitum. Individuals with
evidence of exposure to ‘fast growers ’ (i.e. with induration to antigens from fast growers which
exceeded their sensitivity to tuberculin), but not those exposed to ‘slow growers ’, were at
reduced risk of contracting both tuberculosis and leprosy, compared to individuals whose
indurations to the environmental antigen were less than that to tuberculin. This evidence for
cross protection from natural exposure to certain environmental mycobacteria may explain
geographic distributions of mycobacterial disease and has important implications for the
mechanisms and measurement of protection by mycobacterial vaccines.
INTRODUCTION
Of more than 100 known species of the genus
Mycobacterium, the large majority are described as
‘environmental ’ (or ‘atypical ’) mycobacteria, and are
thought to live as saprophytes in water or soil.
Though these environmental mycobacteria in-
frequently cause disease (in contrast to the obligate
parasites M. tuberculosis and M. leprae), they are of
importance for human health for at least four reasons.
* Author for correspondence.
First, several species have long been known to cause
disease under special circumstances, and are hence
known as ‘opportunistic ’ mycobacteria. Such oppor-
tunities include their presentation in aerosols, allowing
them to reach the peripheral lung fields, and also
immunological inadequacy, due to immaturity as in
cervical lymphadenitis of childhood [1], or due to
immunosuppression induced by high dose cortico-
steroids or by chronic virus infections such as HIV.
Thus M. aium has been a major cause of mortality in
AIDS patients in Europe and North America [2].
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Second, two species are associated predominantly
with skin lesions: M. marinum causes minor granu-
lomatous lesions, and M. ulcerans is responsible for
a severe necrotizing disease, Buruli ulcer, which has
replaced leprosy as the second most common myco-
bacterial disease, after tuberculosis, in parts of West
Africa [3]. Third, these organisms are ubiquitous in
the environment, including piped water supplies, and
commonly contaminate sputum smears and cultures,
leading to false positive diagnoses of tuberculosis,
when these are based upon sputum smear alone [4].
Finally, there is considerable evidence that exposure
of human populations to these organisms can have
immunological effects which may on the one hand
protect against tuberculosis or leprosy (and hence be
important in determining the geographic distribution
of these diseases), and on the other hand may mask
protection by BCG vaccines [5]. Besides these BCG-
related effects, contact with environmental myco-
bacteria probably plays an important role in training
the infant immune system, thereby establishing the
pattern of immunological response to other bacterial,
and perhaps viral, infections, to allergen challenges
and to surveillance for malignant cells. In addition to
these direct implications for human health, myco-
bacteria are important and ubiquitous components of
the normal soil flora, and doubtless play a major
ecological role in the biosphere.
Despite their importance, the environmental myco-
bacteria are little studied and not well understood.
This ignorance is in part a consequence of the
difficulties in working with them: they grow relatively
slowly compared to other bacteria, most require
special decontamination methods to separate them
from the many other microbes which share their
environments, and some have never been grown in
itro at all [6]. Modern methods of identification based
upon DNA probes may facilitate efforts to survey the
environment, but the traditional methods of culture
and skin testing have provided most information to
date. The development of specific skin test reagents
for various environmental mycobacteria, and their use
to survey human populations, was initiated in the
1960s in major studies aimed at understanding
geographic variations in apparent protection imparted
by BCG vaccines [7, 8]. These studies have shown that
human populations in many areas of the world have
been exposed and sensitized to antigens of environ-
mental mycobacteria, and that this exposure may be
particularly intense in the tropical regions. This
geographic association is part of the argument for
their role in determining the low efficacy of BCG in
adults observed in many tropical populations [9].
We here present the results of studies to describe the
environmental mycobacterial flora in a rural district
of northern Malawi, based upon both skin testing and
the isolation and identification of contaminants in
sputum cultures. The work took place within the
context of a large epidemiological study of leprosy
and tuberculosis, and provided an opportunity to test
directly the hypothesis that prior exposure to en-
vironmental mycobacteria influences the risks of these
important mycobacterial diseases.
MATERIALS AND METHODS
The work described here was carried out within what
has become known as the Karonga Prevention Study,
the basic methods of which have been described in
detail elsewhere [10, 11]. In brief, the skin testing
presented in this paper was performed within a total
population survey of the Karonga District population
carried out during 1980–5 (‘LEP-1’). Teams of trained
interviewers and paramedical workers moved sys-
tematically across the district, interviewing and
examining all individuals on a household-by-house-
hold basis. The examinations included inspection for
a BCG scar and application of one or two skin tests,
usually RT23 tuberculin in one arm, and an en-
vironmental mycobacterial antigen in the other arm.
The environmental antigens were applied in suc-
cession, so that all individuals in a given area were
tested with a certain specific environmental antigen,
along with either RT23 tuberculin or a second
environmental antigen.
Antigens
RT23 tuberculin (2 IU) was purchased from the
Danish Statens Serum Institute. Fifteen different
environmental mycobacterial antigens were prepared
(by J.L.S.) from both slow growers (M. aium (2
strains), M. gordonae, M. intracellulare, M. kansasii,
M. marinum, M. scrofulaceum, M. xenopi) and fast
growers (M. chitae, M. fortuitum (3 strains), M.
neoaurum, M. nonchromogenicum, M. accae). Two of
the fortuitum antigens (serotypes 1 and 2-3-4) were
derived from autochthonous strains isolated (by
P.A.J.) from soil samples collected in Karonga
District. All were prepared by sonication in borate-
buffered saline of organisms grown on Sauton’s
medium and sterilized by filtration. The reagents were
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standardized to a concentration equivalent to 2 TU of
RT23 [12].
Skin testing procedure
Skin tests were carried out on the volar surface of the
arm. All tests involved intradermal injection of 0–1 ml
of reagent, with a sterile 26 gauge needle. Tests were
read at 48–72 h, with induration diameters measured
along and across the arm. Average diameters are used
in the analyses presented here.
Tuberculosis and leprosy
Data on tuberculosis and leprosy incidence were
collected by active follow-up of the population within
a second total population survey carried out during
1986–9 (‘LEP-2’) [13]. Diagnostic methods (tubercu-
losis bacteriology and leprosy biopsies) are described
in detail elsewhere [14, 15].
Mycobacterial isolates
In addition to skin test results, we present data on
environmental mycobacteria isolated from sputum
cultures (acid egg medium with and without pyruvate)
of tuberculosis suspects, carried out during 1985–98.
In general, only colonies which looked macro-
scopically as though they might harbour M. tu-
berculosis were sent for species identification (to
P.A.J. until 1996 and to M.Y. thereafter).
Data handling and statistical analyses
All data were coded at project headquarters in
Malawi, entered on computers and accumulated on
databases at the London School of Hygiene and
Tropical Medicine in London. Analyses presented
here were performed in STATA, using logistic and
Poisson regression. In order to examine the as-
sociation of prior sensitivity to mycobacteria with
tuberculosis and leprosy, we have compared pooled
data on slow growers with those from fast growers, as
there were insufficient cases among those tested with
single antigens. Because of evidence for cross-re-
activity between antigens, we assume that individuals
with skin test induration to antigen X which is greater
than their induration to RT23 tuberculin are more
likely to have been infected with Mycobacterium X
than are those whose induration to antigen X is less
than that to tuberculin. Cases of TB and leprosy that
arose within 6 months of skin-testing, and individuals
whose tuberculin test and environmental myco-
bacterial test were read more than 6 h apart, were
excluded from the incidence rate analyses.
RESULTS
Results are available from 31044 individuals dual-
tested with both an environmental mycobacterial
antigen and RT23 tuberculin, and from 5146 indi-
viduals for whom the second test was not with RT23.
Table 1 shows the numbers of tests carried out with
each of the antigens, during the LEP-1 survey.
Frequency distributions of induration sizes for each
antigen are presented in Fig. 1. We see that, for each
of these antigens, some individuals developed no
apparent response at all, and others developed
indurations of roughly 5–15 mm, with a mode near
10 mm. Though the illustrated distributions are for all
ages combined, the age, sex and BCG scar status
distributions of the separate tested populations are
sufficiently similar for them to be compared. In
addition, Table 1 shows, for each antigen, the
prevalence of sensitivity (defined as induration
& 5 mm, column 3; or & 10 mm, column 4),
standardized for age, sex and BCG-scar status. Using
these criteria, the prevalence of sensitivity is seen to
vary greatly between the different mycobacterial
reagents, with M. intracellulare and M. scrofulaceum
the highest, and M. xenopi the lowest.
For each antigen, the proportion of individuals
with sensitivity greater than any given criterion
increased with age. For most of the antigens these
proportions were significantly higher among indi-
viduals with than among those without BCG scars.
This BCG effect was particularly strong for the slow
growers in general, and least convincing for M.
fortuitum, M. gordonae and M. nonchromogenicum.
The proportion with induration & 5 mm was similar
for male and female children, but higher among males
than among females for individuals above 15 years of
age except for M. chitae, M. fortuitum, M. gordonae
and M. xenopi. These trends are illustrated in Fig. 2
for M. scrofulaceum and M. neoaurum. For each
antigen, the significance of the interaction between
age and sex is indicated in column 7, and the
significance of the BCG effect is indicated in column
9, of Table 1.
The last two columns in Table 1 present results for
those environmental mycobacterial reagent tests
which were paired with RT23 tuberculin, and are here
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Table 1. Summary of data on enironmental mycobacterial skin tests carried out in Karonga district, northern Malawi, 1980–4. Prealences (columns 3 and
4) refer to indiiduals greater than 20 years of age, and are age–sex-BCG standardized against the total RT23 population. The last two columns are
restricted to tests paired with RT23 tuberculin, and adjusted for RT23 induration
Mycobacterium n
& 5 mm
(%)
& 10 mm
(%)
OR, female to male* (95% C.I.)
Age by sex
interaction
P value
OR, BCG
positive to
BCG negative
(95% C.I.)
BCG
effect
P value
Adjusted for RT23 induration
in paired test
! 15 years & 15 years
Deviance
change when
include RT23
Age-sex
interaction
(P value)
Slow growers
M. aium (A) 2623 58 42 1–02 (0–79, 1–32) 0–68 (0–54, 0–85) 0–019 1–17 (0–97, 1–42) 0–101 0–216 0–058
M. aium (B) 1699 32 18 0–93 (0–59, 1–46) 0–57 (0–42, 0–76) 0–074 1–74 (1–27, 2–38) ! 0–001 0–222 0–206
M. gordonae 2014 14 7 0–63 (0–41, 0–99) 0–55 (0–40, 0–77) 0–635 1–28 (0–93, 1–75) 0–123 0–120 0–184
M. intracellulare 2886 77 60 1–15 (0–93, 1–42) 0–67 (0–50, 0–90) 0–003 1–39 (1–15, 1–68) ! 0–001 0–154 0–157
M. kansasii 2393 59 44 0–97 (0–72, 1–29) 0–41 (0–32, 0–53) ! 0–001 1–80 (1–46, 2–23) ! 0–001 0–276 ! 0–001
M. marinum 3020 59 44 1–04 (0–84, 1–29) 0–59 (0–48, 0–73) ! 0–001 1–81 (1–51, 2–18) ! 0–001 0–315 0–044
M. scrofulaceum 3324 77 66 1–15 (0–95, 1–40) 0–48 (0–37, 0–62) ! 0–001 1–55 (1–30, 1–86) ! 0–001 0–157 ! 0–001
M. xenopi 3010 11 6 0–20 (0–09, 0–45) 0–38 (0–28, 0–50) 0–125 1–54 (1–15, 2–07) 0–004 0–064 0–854
All slow growers 20969 48 36
Fast growers
M. chitae 3232 47 29 0–98 (0–78, 1–23) 0–83 (0–68, 1–01) 0–283 1–27 (1–06, 1–51) 0–008 0–125 0–914
M. fortuitum (A) 1744 44 31 1–01 (0–75, 1–37) 0–88 (0–67, 1–15) 0–492 1–07 (0–85, 1–35) 0–560 0–108 0–880
M. fortuitum (1) 1139 24 8 1–23 (0–60, 2–56) 0–52 (0–34, 0–78) 0–040 1–26 (0–81, 1–96) 0–309 0–136 0–050
M. fortuitum (2-3-4) 3271 71 53 0–82 (0–67, 1–01) 0–89 (0–71, 1–11) 0–624 0–95 (0–80, 1–12) 0–515 0–086 0–574
M. neoaurum 3465 43 31 1–26 (0–99, 1–60) 0–64 (0–53, 0–78) ! 0–001 1–29 (1–08, 1–55) 0–005 0–145 0–001
M. nonchromogenicum 1488 50 34 0–97 (0–64, 1–46) 0–42 (0–31, 0–56) 0–001 1–15 (0–86, 1–55) 0–348 0–151 0–020
M. accae 882 43 33 1–09 (0–71, 1–66) 0–54 (0–37, 0–80) 0–018 1–39 (0–99, 1–96) 0–059 0–105 0–035
All fast growers 15221 46 31
RT23 48128 59 48 0–92 (0–86, 0–98) 0–61 (0–58, 0–65) ! 0–001 1–90 (1–81, 1–99) ! 0–001
* OR is for the odds of having an induration of & 5 mm.
 test for whether female to male odds ratio of having an induration of & 5 mm is different for those aged less than 15 years compared to those aged 15 or over.
 RT23 induration was categorised as 0 mm, 1–5 mm, 6–10 mm, 11–15 mm, " 15 mm.
 (change in model deviance when include RT23 induration as a predictor of NTM induration)}(number of observations in data set). Reflects strength of association between
RT23 induration and NTM induration, standardized for size of data set (all associations P! 0.0001).
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Fig. 1. Frequency distributions of skin test indurations to environmental mycobacterial antigens, Karonga District, northern
Malawi, 1980–5: (a) slow growers ; (b) fast growers.
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Fig. 2. Percentage with skin test induration & mm for (a)
M. scrofulaceum and (b) M. neoaurum antigens, by age
group, sex and BCG scar status : Karonga District, northern
Malawi, 1980–5. +, M BCG ›ve; *, M BCG five; E, F
BCG ›ve; D, F BCG five.
Table 2. Enironmental mycobactria species (or
species groups) identified in sputum samples collected
in Karonga District, northern Malawi, 1985–98
Slow growers Fast growers
Species (group) n Species (group) n
M. aium-intracellulare 249 M fortuitum 117
M. gordonae 41 M chelonae 8
M. terrae 30 M flaescens 5
M. kansasii 17 M smegmatis-phlei 5
M. malmoense 2
Total 339 Total 135
adjusted for the RT23 tuberculin induration. Column
10 provides a measure of the strength of the
association between the induration to an environ-
mental mycobacterial reagent and the induration to
RT23, and column 11 shows the age–sex interaction
after controlling for RT23 induration as a predictor of
induration to the environmental mycobacterial anti-
gen.
Table 2 shows the numbers of isolates of different
environmental mycobacteria identified in sputum
cultures collected from tuberculosis suspects between
1985 and 1998. Members of the M. aium–
intracellulare complex were most commonly found,
followed by M. fortuitum. Interestingly, the relative
frequency of these species corresponds to the relative
prevalence of sensitivity to their antigens, as shown in
Table 1 (columns 3 and 4). Several other species were
identified less commonly in these cultures.
The implications of prior sensitivity to slow or to
fast growing environmental mycobacteria for sub-
sequent incidence of tuberculosis and leprosy are
explored in Table 3. These are expressed as rate ratios
(with 95% CI), comparing the incidence among
individuals whose prior sensitivity to the environ-
mental mycobacterial antigen was greater than that to
RT23, to the incidence among individuals whose
sensitivity to the environmental mycobacterial antigen
was less than or equal to that to RT23. We see
evidence (P! 0–10 for TB and Pfl 0–05 for leprosy)
that prior sensitivity to antigens of fast growers, but
not to antigens of slow growers, was associated with
low risks of both leprosy and tuberculosis.
DISCUSSION
These data show that a variety of different en-
vironmental mycobacteria are present in Karonga
District, and that many people living there have been
sensitized by or to their antigens. Nine different
‘species ’ (or species groups) have been identified to
date in sputum cultures, as shown in Table 2. We do
not know the actual source of these organisms. It is
likely that several of them had colonized or infected
the individuals who provided the sputum samples, but
others probably arose through contamination of the
sputa either in the field, or in the laboratory. We have
been unable to identify evidence of contamination in
the laboratory, in terms of clusters of specimens with
the same environmental mycobacterium processed on
the same day, but nonetheless expect that some of the
isolates originated in this way. We note that more
slow-growing than fast-growing organisms were
identified in the sputa. This should be interpreted with
caution, however, since fast-growers tend to be more
susceptible to sputum decontamination techniques
than are slow growers, and sputum cultures were in
general only sent to the reference laboratory for
species confirmation if the primary isolates looked as
though they might be M. tuberculosis (16% of cultures
grew something which was ultimately sent to a
reference laboratory). Some mycobacteria such as
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Table 3. Implications of prior sensitiity to enironmental mycobacteria for subsequent incidence rates of
tuberculosis and leprosy, Karonga District, northern Malawi, 1980–90
Tuberculosis Leprosy
t}pyears* rate ratio (95% CI) P value l}pyears* rate ratio (95% CI) P value
Slow growers
NTM%RT23 15}65869 51}50892
NTM"RT23 4}19608 1.08 (0.34, 3.43) 0.899 14}14787 1.09 (0.59, 2.02) 0.788
Fast growers
NTM%RT23 26}542352 30}41044
NTM"RT23 2}15213 0.32 (0.07, 1.39) 0.080 2}11488 0.29 (0.07, 1.25) 0.050
Incidence rate ratios (with 95% confidence intervals) compare the incidence among individuals whose prior sensitivity to the
environmental mycobacterial antigen was greater than that to RT23 tuberculin (NTM"RT23), to the incidence among
individuals whose sensitivity to the environmental mycobacterial antigen was (less than or equal to) that to RT23
(NTM%RT23).
* t}pyears TB cases}person-years ; l}pyears, leprosy cases}person-years.
 Adjusted for age, sex, BCG scar status, and RT23 induration; RT23 induration categorised as 0 mm, 1–5 mm, 6–10 mm,
11–15 mm, " 15 mm.
 P value is for likelihood ratio test ; Wald test, to which (approximate) 95% CI relate, gives slightly higher P values
 Adjusted for age, sex, BCG scar status, zone and RT23 induration; RT23 induration categorized as 0 mm, 1–5 mm,
6–10 mm, 11–15 mm, " 15 mm.
M. gordonae, M. scrofulaceum and M. neoaurum can
produce bright yellow colonies which do not look like
those of tubercle bacilli, and are thus less likely to
have been submitted for investigation in this study. A
special investigation is now underway to identify
where in the environment these various organisms
normally live.
In addition to the direct evidence of these isolated
organisms, we have evidence of widespread skin test
sensitivity to antigens of various environmental
mycobacteria (Table 1, Figs 1 and 2). Though the
frequency distributions of skin test induration to each
of the antigens look bimodal (some individuals with
no sensitivity, and some with a range of indurations,
typically around 10 mm), we wish to avoid a simplistic
interpretation of test ‘‘positivity ’’. The significant
association between sensitivity to most of the antigens
(as defined by induration of at least 5 or 10 mm) with
the presence of a BCG scar indicates that the delayed-
type hypersensitivity should not be interpreted as
specific evidence of exposure to that organism. This is
not surprising, as it is well known that members of the
genus Mycobacterium share many antigens in com-
mon. This cross-reactivity is also evident in these
analyses in the association of sensitivity between the
various antigens and RT23, which was very strong,
and particularly the fact that the strength of this
association increased with phylogenetic closeness to
M. tuberculosis. Thus evidence of association was
strongest for M. marinum and M. kansasii, followed
by M. aium, M. scrofulaceum and M. intracellulare.
There is also evidence for antigen specificity in these
data, in the different prevalences of the various
antigens, and the fact that the high relative prevalence
of sensitivity to M. aium (A), M. intracellulare and
M. fortuitum (2-3-4) correspond to their relative
frequencies of these species among sputum con-
taminants (see Tables 1, 2). In this context, the
relatively low prevalence of skin test responses to the
M. gordonae reagent, in relation to the culture
isolation figures, may be due to variation within this
species, and the fact that the skin test reagent was
prepared from the type strain originating from Central
America.
We find that prevalence of sensitivity to all of the
antigens is similar among male and female children
(! 15 years of age) but that for most (9}15) of the
antigens the prevalence of sensitivity is significantly
higher among males for adults. This interaction
remains significant for 6 out of the 12 environmental
mycobacteria (and to antigens from one strain of M.
fortuitum) after adjustment for RT23 sensitivity
(Table 1). Such an age–sex interaction has long been
known for tuberculin [16], and has been reported for
M. intracellulare [17]. There are three potential
explanations for this pattern. First, it may indicate
that males are consistently more exposed to these
antigens than are females. This hypothesis is difficult
to test, but it does not fit obviously with our
observations of the Karonga population. Both males
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and females work in agricultural fields, and females
have much more contact than males to water sources
such as streams and boreholes, which are often
surrounded by muddy areas. Second, it may reflect
shared antigenicity with the tubercle bacillus, and
hence be a reflection of greater exposure of males to
tubercle bacilli, (if indeed the higher prevalence of
sensitivity to tuberculin reflects exposure to infection
with M. tuberculosis). The fact that the age–sex
interaction remains after adjustment for RT23 for half
the environmental mycobacteria tested is evidence
against this hypothesis. Thirdly, it may reflect a
greater propensity for males, compared to females,
to develop a delayed type hypersensitivity response to
mycobacterial antigens. We favour the latter hypothe-
sis, noting its corollary, that the greater sensitivity
to tuberculin among adult males compared to adult
females is also at least in part a reflection of this
physiological difference. Such a physiological dif-
ference has been suggested by other workers [6, 18]. It
is potentially important for our general understanding
of tuberculosis, as it implies a sex difference in the
sensitivity and specificity of tuberculin reactivity in
humans, which has not been appreciated heretofore.
It should be noted that these data were collected
during the early and mid 1980s, when the prevalence
of HIV was less than 1% in this population. The
patterns observed were thus not a reflection of HIV-
attributable immunosuppression.
The indication in these data of reduced risks of both
leprosy and tuberculosis associated with prior sen-
sitivity to fast-growing, but not to slow-growing
environmental mycobacteria is particularly intriguing.
The associations (Pfl 0–05 for leprosy and P! 0–1 for
tuberculosis) are present after adjustment for RT23
sensitivity, and are thus not merely a reflection of
relatively low RT23 sensitivity in individuals with
greater induration to the environmental
mycobacteria – let alone the fact that low RT23
sensitivity is associated with low tuberculosis in-
cidence but high leprosy incidence [19]. That sen-
sitivity to antigens of fast but not of slow growers
should be associated with reduced risks of both
diseases was contrary to the initial hypothesis of some
of the authors, who had expected that natural
protection would be more likely from exposure to the
more closely related slow-growing organisms (the
closest precedent for such an analysis is in data from
US naval recruits suggesting low tuberculosis in-
cidence associated with sensitivity to antigens of M.
intracellulare, a slow grower [20]). The argument by
genetic proximity has been countered by others among
us who have argued that fast-growing mycobacteria
tend to be better adjuvants for protective immune
responses than are slow growers [21, 22]. The rate
ratios observed here appear to support the latter
hypothesis. If delayed-type hypersensitivity to either
the tubercle or leprosy bacilli were not protective, but
adversely pre-sensitizing, perhaps via TH2 adjuvant
activity, this may predispose to an adverse clinical
outcome if an individual is later exposed to and
infected by the pathogen [23]. Such an explanation
would fit with several lines of evidence indicating the
dissociation of DTH and of protective immunity
[19, 24].
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